The Mounjaro maximum dose: what 15mg means in practice

The myth worth correcting: higher dose does not automatically mean better results

A common assumption (and a question our prescribers hear most weeks) is that 15mg is simply the goal, and that any dose below it is somehow insufficient. That framing gets the logic backwards. The titration schedule exists primarily to give your body time to adjust. Gastrointestinal side effects such as nausea, indigestion and altered bowel habits are most pronounced early in treatment and after dose increases; moving more slowly reduces them. Arriving at the highest dose too fast does not improve outcomes, it tends to worsen tolerability and can lead people to stop treatment altogether.

The clinical evidence also shows meaningful weight loss at doses well below 15mg. In the SURMOUNT-1 trial, participants on 10mg tirzepatide lost an average of around 19% of body weight over 72 weeks, a result that is clinically substantial on its own. You can read more about how the full Mounjaro dosage schedule is structured and what each step is designed to achieve.

The practical point is this: your prescriber is looking for the dose at which you are losing weight at a meaningful rate and tolerating treatment well. That may be 10mg. It may be 12.5mg. It may eventually be 15mg. There is no clinical rule that says the maximum dose is always the right one for you.

What the licensed schedule actually looks like on the way to 15mg

Mounjaro treatment begins at 2.5mg. The opening pen's job is adjustment, settling your digestive system before the dose with any real appetite-suppressing effect takes hold. After four weeks, the dose typically steps up to 5mg, and from there the pattern continues in 2.5mg increments approximately every four weeks: 7.5mg, 10mg, 12.5mg, and finally 15mg.

That means the earliest anyone reaches the maximum dose is around five months into treatment, and many people spend longer at intermediate steps. A prescriber may slow the schedule if side effects are significant, or hold a dose if the clinical picture suggests that is the right call. The 5mg dose, for instance, is where many people first notice appetite suppression becoming consistent, that experience varies, and tolerability data from your own treatment matters to the prescriber's decisions that follow.

At num, every dose increase requires a clinical re-review. Evidence of how the current dose is working (and how you are feeling on it) is assessed before a step up is confirmed. The full picture of Mounjaro dosing, including what each strength does, covers this in more detail. Missed doses, timing adjustments and anything that changes your schedule should always be directed to your prescriber and the Patient Information Leaflet, not general guidance online.

Who can reach 15mg, and when it makes clinical sense

Mounjaro is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above where at least one weight-related condition is present, such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Eligibility for any particular dose is not a separate question from eligibility for treatment; the same prescription covers the whole schedule.

In clinical practice, the case for moving to 15mg is strongest when someone is tolerating their current dose well, has not yet reached a stable and clinically meaningful rate of weight loss, and has no contraindications to continuing. NICE's appraisal of tirzepatide (NICE TA1026) notes that if less than 5% weight loss has occurred after six months at the highest tolerated dose, the appropriateness of continuing treatment should be reviewed, a reminder that dose alone is not the story.

For context on how tirzepatide's maximum dose compares to other approaches, the tirzepatide maximum dose for weight loss page covers the evidence and the licensed ceiling in more detail. If you are curious about how the Mounjaro treatment works more broadly, that overview is a good starting point before consulting a prescriber.

A note on getting there safely through a regulated service

Because dose increases require clinical oversight, the route you take to treatment matters. The NHS describes these as prescription-only medicines requiring proper assessment, not a box to tick, but a genuine clinical process. Pens sold online without a prescription, or through sellers who offer dose-escalation without review, carry real risks: counterfeit products, wrong doses, and no one monitoring your safety.

The process of accessing Mounjaro through a regulated online pharmacy should involve identity verification, weight checks and a prescriber reviewing your case before each step. At a regulated pharmacy you can verify on the GPhC register, the dispensing and prescribing infrastructure has to meet national standards. That matters most at higher doses, where the clinical picture is more complex.

The weight loss treatment overview explains what a compliant private route looks like. If you want to understand your own situation and whether the maximum dose of Mounjaro might be appropriate for you, a conversation with a prescriber is the only way to get a reliable answer. Start your free consultation and a GPhC-registered prescriber will review your details the same day.